Stanford Medical School Shield
 
ARAMIS button
investigators button
research button
publications button
HAQ button
pharmaceutical collaborations button
 
Link to Main Stanford Medical School Site
 Heading Filler Publications Page Heading
Clear Spacer  
 

    1995

  • Altman RD, Hochberg M, Murphy WA, Jr., Wolfe F, Lequesne M. Atlas of individual radiographic features in osteoarthritis. Osteoarthritis Cartilage. 1995;3 Suppl A:3-70.
  • Callahan LF, Pincus T. The sense of coherence scale in patients with rheumatoid arthritis. Arthritis Care Res. 1995;8(1):28-35.
  • Clarke AE, Bloch DA, Medsger TA, Jr., Oddis CV. A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis. Arthritis Rheum. 1995;38(9):1218-24.
  • Fries J. The toxicity of anti-rheumatic drugs: Problems and solutions. Proc R Coll Physicians Edinb. 1995;25:398-405.
  • Fries J. A new treatment approach: DMARD-based sequential therapy. Hosp Pract. 1995:23-30.
  • Fries JF. ARAMIS and toxicity measurement. (Arthritis Rheumatism and Aging Medical Information System). J Rheumatol. 1995;22(5):995-7.
  • Fries JF, Singh G. Glucocorticoids and joint destruction in rheumatoid arthritis. N Engl J Med. 1995;333(23):1569; discussion 1570.
  • Gonzalez VM, Stewart A, Ritter PL, Lorig K. Translation and validation of arthritis outcome measures into Spanish. Arthritis Rheum. 1995;38(10):1429-46.
  • Hornberger J, Habrakan H, Bloch D. Minimum data needed on patient references for accurate, efficient medical decision making. Med Care. 1995;33:297-310.
  • Lane NE, Mroczkowski PJ, Hochberg MC. Prevention and management of glucocorticoid-induced osteoporosis. Bull Rheum Dis. 1995;44(5):1-4.
  • Lane NE, Pressman AR, Star VL, Cummings SR, Nevitt MC. Rheumatoid arthritis and bone mineral density in elderly women. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1995;10(2):257-63.
  • Lorig K. Patient education: treatment or nice extra. Br J Rheumatol. 1995;34(8):703-4.
  • Lorig K. Arthritis self-help course. HMO Pract. 1995;9(2):60-1.
  • Lubeck DP. The economic impact of arthritis. Arthritis Care Res. 1995;8(4):304-10.
  • Mata S, Wolfe F, Joseph L, Esdaile JM. Absence of an association of rheumatoid arthritis and diffuse idiopathic skeletal hyperostosis: a case-control study. J Rheumatol. 1995;22(11):2062-4.
  • McDermott M, Kastner DL, Holloman JD, et al. The role of T cell receptor beta chain genes in susceptibility to rheumatoid arthritis. Arthritis Rheum. 1995;38(1):91-5.
  • Pincus T. Assessment of long-term outcomes of rheumatoid arthritis. How choices of measures and study designs may lead to apparently different conclusions. Rheum Dis Clin North Am. 1995;21(3):619-54.
  • Pincus T. Long-term outcomes in rheumatoid arthritis. Br J Rheumatol. 1995;34 Suppl 2:59-73.
  • Pincus T. Why should rheumatologists collect patient self-report questionnaires in routine rheumatologic care? Rheum Dis Clin North Am. 1995;21(2):271-319.
  • Pincus T. The underestimated long term medical and economic consequences of rheumatoid arthritis. Drugs. 1995;50(Suppl 1):1-14.
  • Pincus T, Callahan LF. Prognostic markers of activity and damage in rheumatoid arthritis: why clinical trials and inception cohort studies indicate more favourable outcomes than studies of patients with established disease. Br J Rheumatol. 1995;34(3):196-9.
  • Pincus T, Callahan LF, Fuchs HA, Larsen A, Kaye J. Quantitative analysis of hand radiographs in rheumatoid arthritis: time course of radiographic changes, relation to joint examination measures, and comparison of different scoring methods. J Rheumatol. 1995;22(10):1983-9.
  • Pincus T, Stein CM. What is the best source of useful data on the treatment of rheumatoid arthritis: clinical trials, clinical observations, or clinical protocols? J Rheumatol. 1995;22(9):1611-7.
  • Poole JL, Williams CA, Bloch DA, Hollak B, Spitz P. Concurrent validity of the Health Assessment Questionnaire Disability Index in Scleroderma. Arthritis Care Res. 1995;8(3):189-93.
  • Radis CD, Kahl LE, Baker GL, et al. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study. Arthritis Rheum. 1995;38(8):1120-7.
  • Sampalis JS, Esdaile JM, Medsger TA, et al. A controlled study of the long-term prognosis of adult Still's disease. Am J Med. 1995;98(4):384-8.
  • Ward MM, Hubert HB, Shi H, Bloch DA. Physical disability in older runners: prevalence, risk factors, and progression with age. J Gerontol A Biol Sci Med Sci. 1995;50(2):M70-7.
  • Ward MM, Rao R. Interruptions in rheumatology subspecialty care among patients with rheumatoid arthritis. J Rheumatol. 1995;22(12):2319-26.
  • Wolfe F. A database for rheumatoid arthritis. Rheum Dis Clin North Am. 1995;21(2):481-500.
  • Wolfe F. Health status questionnaires. Rheum Dis Clin North Am. 1995;21(2):445-64.
  • Wolfe F. The epidemiology of drug treatment failure in rheumatoid arthritis. Baillieres Clin Rheumatol. 1995;9(4):619-32.
  • Wolfe F, Pincus T. Data collection in the clinic. Rheum Dis Clin North Am. 1995;21(2):321-58.
  • Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38(1):19-28.
 

ARAMIS |  Investigators |  Research |  Publications |  HAQ |  Pharmaceutical Collaborations

©2001 Stanford University. All Rights Reserved. If you experience any difficulty with this site, please email our webmaster. Last updated October 2001.